PMC9393292_01
Trend of hematologic parameters over times.
fped-10-935118-g001.jpg
PMC9393292_01_fped-10-935118-g001.jpg
F1
The WBC and N counts decreased again on day 8 and stabilized after the complete course of nirmatrelvir/ritonavir treatment (Figure 1), accompanied by the relief of clinical symptoms.
Trend of Ct values of ORF1a/b and N genes over times.
fped-10-935118-g002.jpg
PMC9393292_01_fped-10-935118-g002.jpg
F2
The cycle threshold (Ct) values of ORF1a/b and N gene fragments increased from 22.60 and 22.15 to 34.52 and 33.84, respectively, following the 5-day full course of nirmatrelvir/ritonavir treatment (Figure 2).